Medical Device Analytical Testing Outsourcing Market
Market Insights on Medical Device Analytical Testing Outsourcing covering sales outlook, demand forecast & up-to-date key trends
Medical Device Analytical Testing Outsourcing Market by Service, Device Type, End Use & Region - Forecast 2022 - 2032
Medical Device Analytical Testing Outsourcing Market Outlook (2022-2032)
[324 Pages Report] The ubiquitous medical device analytical testing outsourcing market garnered US$ 5.11 Billion in 2021, and is credibly to exhibit a CAGR of 7.18% surpassing a valuation of US$ 10.96 Billion in 2032. Owing to the product complexity, greater competition, a growth in the number of small-scale medical device makers, and stringent clearance standards are all factors.
Many medical device businesses outsource analytical testing activities to avoid business risks, accelerate product market launch, and save money. These procedures result in considerable increases in spending levels, prompting original equipment makers of medical devices to quickly shift to outsourcing as one of the most efficient cost-cutting methods.
Implantable Medical Devices (IMDs) are increasingly being employed to enhance the health outcomes of patients. IMD designers must strike a compromise between complexity, dependability, power consumption, and cost.
|
Attributes |
Details |
|
Global Medical Device Analytical Testing Outsourcing Market CAGR (2022-2032) |
7.18% |
|
Global Medical Device Analytical Testing Outsourcing Market (2032) |
US$ 10.96 Billion |
|
Global Medical Device Analytical Testing Outsourcing Market Attraction |
Product complexity, increased rivalry, an increase in the number of small-scale medical device manufacturers, and high clearance criteria are all primary drivers in the industry. |
As a result, businesses are moving their emphasis to innovation rather than non-core tasks and, as a result, outsourcing these services to create efficient instruments. Over the projected period, all of these factors are likely to boost the market.
North America accounted for a large market share due to its status as one of the leading production centers for highly dependable complicated, and high-end medical equipment, as well as the presence of several service providers.
Let us know your requirement to get
100% FREE customization
What are the Key Factors Propelling the Medical Device Analytical Testing Outsourcing Market Growth?
Rising global incidence of chronic illnesses will benefit the market in the coming time
The rising global incidence of chronic illnesses is driving the demand for medical device analytical testing outsourcing.
The government's increasingly strict quality certificate standards are moving the worldwide medical device analytical testing outsourcing market forward.
Class II devices require premarket approvals and 510 (k) clearance; yet, obtaining such clearance is a time-consuming procedure; hence, such new circumstances have fueled the expansion of the global medical device analytical testing outsourcing market.
What are the Major Trends in the Global Medical Device Analytical Testing Outsourcing Market?
Medical device makers are hiring consultants to help them grasp the documents and laws required for pre-market clearance. The development of modern technologies such as surgical microscopes, surgical robots, neurosurgical devices, ophthalmic surgical devices, and many others has reduced the direct interaction of people in the surgical procedure, making quality certifications for medical devices vital.
The increased need for minimally invasive operations is driving the ubiquitous medical device analytical testing outsourcing market forward.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Challenges are in Store for Medical Device Analytical Testing Outsourcing Sales?
Although, outsourcing reduces the costs of such operations, which is projected to drive market expansion. Medical Device Analytical Testing Outsourcing Market has its fair share of drawbacks.
The primary drawback of medical device analytical testing outsourcing resides in the third-world countries which might still be price-sensitive for medical device analytical testing, which is a key impediment to the medical device analytical testing outsourcing industry.
Comparative View of Adjacent Medical Device Analytical Testing Outsourcing Market
Medical Device Analytical Testing Outsourcing Market:
|
Attributes |
Medical Device Analytical Testing Outsourcing Market |
|
CAGR (2022-2032) |
7.18% |
|
Market Value (2032) |
US$ 10.96 Billion |
|
Growth Factor |
Medical device analytical testing outsourcing contributes to the quality and accuracy of these devices. Outsourcing lowers the costs of such operations, which is projected to drive market expansion. |
|
Opportunity |
On a worldwide basis, medical device reprocessing is still in its early phases, but it has already been proved to give considerable benefits to healthcare providers, hence propelling the expansion of the medical device analytical testing outsourcing market. |
Sterility Testing Market:
|
Attributes |
Sterility Testing Market |
|
CAGR (2022-2032) |
4.6% |
|
Market Value (2032) |
US$ 2.5 Billion |
|
Growth Factor |
The expansion of the pharmaceutical and biotechnology industries, as well as fast innovation, are driving the growth of the sterility testing market. New clinical trials and medication releases are growing the market even further. |
|
Opportunity |
Companies are working on research and development and making investments a large amount of money for better results, which is supported by favourable government support for the pharmaceutical and biotech industries, which is likely to motivate the market and drive growth, as well as create opportunities for new players to enter the market and invest. |
Cardiology Electrodes Market:
|
Attributes |
Cardiology Electrodes Market |
|
CAGR (2022-2032) |
4.6% |
|
Market Value (2032) |
US$ 150 Billion |
|
Growth Factor |
The worldwide cardiology electrodes market is expected to be driven by an increase in the incidence of cardiovascular illnesses. |
|
Opportunity |
Increased efforts to improve the diagnosis and treatment of patients with heart rhythm problems, as well as to reduce the societal burden and improve patient outcomes, provide substantial prospects in the worldwide cardiology electrodes market. |
A unified Market Research Subscription Platform, built for today's disparate research needs.
Segmental Analysis
Which End Use Segment is expected to lead the Global Medical Device Analytical Testing Outsourcing Market?
Based on end use, the ubiquitous market has been further subdivided into hospitals and others based on end-uses. In 2021, the hospitals sector led the global market, accounting for more than 86.00% of global revenue. This expansion can be attributable to increasing patient traffic and higher hospital administration budget allocation for these operations.
Another important element boosting the use of analytical testing for such devices is the increasing need for innovative technology-based medical devices across healthcare facilities. The facilities contain cutting-edge new technology-based medical gadgets that require effective analytical testing for improved performance, hence boosting market growth.
Furthermore, hospital facilities are the primary providers of refurbished medical equipment that require analytical services, making them one of the leading platforms that outsource these services to contract developers.
Other healthcare venues, such as diagnostic centers, ambulatory care centers, and specialized care centers, are likely to gain substantial market share in the coming years. Hospitals are further subdivided into equipment and consumables. The equipment category was responsible for roughly 39.5% of hospital-based medical equipment analytical testing services in 2021. These gadgets include cardiology equipment, imaging equipment, surgical microscopes, surgical instruments, and therapeutic and monitoring devices. This equipment is purchased for long-term use, and calibration, preventative maintenance, and performance reviews are contracted out.
What is the Regional Analysis of the Global Medical Device Analytical Testing Outsourcing Market?
In 2021, Asia Pacific led the worldwide market, accounting for more than 41% of global revenue. The regional market is expected to increase at the quickest CAGR throughout the projection period, preserving its leadership position. This expansion can be linked to government initiatives to strengthen the region's healthcare infrastructure.
Furthermore, developments in India and China's economies are projected to stimulate market expansion. Because of the region's enormous population base and low per capita income, there is a high demand for cost-effective treatment options. Multinational firms are keen to invest in emerging markets like India and China.
North America is also expected to increase significantly throughout the predicted period. The fact that this regional market is one of the most significant production hubs for exceptionally dependable, complex, and high-end medical items is largely responsible for its rise.
As a result, to manage the rising amount of electronic components in today's medical equipment, Original Equipment Manufacturers (OEMs) are increasingly turning to electronics manufacturing service providers. One of the key drivers driving the market is expected to be a quick expansion in the manufacture of medical devices to meet the region's rising need for better healthcare.
|
Country |
Estimated CAGR |
|
U.S |
7% |
|
U.K |
6% |
|
China |
5.5% |
|
Japan |
4.5% |
|
India |
5% |
What is the Intensity of the Competition in the Global Medical Device Analytical Testing Outsourcing Market?
Eminent players of the global Medical Device Analytical Testing Outsourcing market include SGS, Toxikon, Inc, and Eurofins Scientific, Pace Analytical Services LLC, Intertek Group plc, Wuxi AppTec, North American Science Associates, Inc., Envigo, Charles River Laboratories International, Inc. and Medical Device Testing Services
Some of the recent developments in the global Medical Device Analytical Testing Outsourcing market are:
- In May 2022, Intertek renews its contract with the Philippines Bureau of Customs for its Bulk and Break Bulk Cargo Clearance Enhancement Programme.
- In May 2022, Intertek announced the launch of 'Intertek Hydrogen’ which assists the hydrogen industry in commercializing ground-breaking technology securely into the future.
- In May 2022, WuXi AppTec has formed the HitS (Hit Success) business unit to merge upstream and downstream DEL technologies to better enable the early stage drug development process. WuXi's mission is to increase R&D productivity by producing more and better hit compounds and laying the groundwork for further Med-Chem optimization.
- In June 2022, Charles River Laboratories International, Inc. announced that it will speak at the Jefferies Healthcare Conference on Wednesday, June 8th, at 10:00 a.m. ET, and the William Blair 42nd Annual Growth Stock Conference on Thursday, June 9th, at 10:40 a.m. CT. Charles River's strategic emphasis and business developments will be presented by management.
Scope of Report
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 7.18% from 2022 to 2032 |
|
Market Value for 2022 |
US$ 5.48 Billion |
|
Market Value for 2032 |
US$ 10.96 Billion |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2017-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
USD Million for Value |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Report Customization & Pricing |
Available upon Request |
Key Segments Covered in the Medical Device Analytical Testing Outsourcing Industry Report
Medical Device Analytical Testing Outsourcing Market by Service:
- Extractable and Leachable Medical Device Analytical Testing Outsourcing
- Material Characterization Medical Device Analytical Testing Outsourcing
- Physical Testing Medical Device Analytical Testing Outsourcing
- Bioburden Testing Medical Device Analytical Testing Outsourcing
- Sterility Testing Medical Device Analytical Testing Outsourcing
- Other Tests Medical Device Analytical Testing Outsourcing
Medical Device Analytical Testing Outsourcing Market by Device Type:
- Reprocessed Devices Medical Device Analytical Testing Outsourcing Market
- Others Medical Device Analytical Testing Outsourcing Market
Medical Device Analytical Testing Outsourcing Market by End Use:
- Medical Device Analytical Testing Outsourcing for Hospitals
- Others
Medical Device Analytical Testing Outsourcing Market by Therapeutic Areas:
- Medical Device Analytical Testing Outsourcing for Cardiology
- Medical Device Analytical Testing Outsourcing for Diagnostic Imaging
- Medical Device Analytical Testing Outsourcing for Orthopedic
- Medical Device Analytical Testing Outsourcing for IVD
- Medical Device Analytical Testing Outsourcing for Ophthalmic
- Medical Device Analytical Testing Outsourcing for General & Plastic Surgery
- Medical Device Analytical Testing Outsourcing for Drug Delivery
- Medical Device Analytical Testing Outsourcing for Endoscopy
- Medical Device Analytical Testing Outsourcing for Dental
- Medical Device Analytical Testing Outsourcing for Diabetes Care
- Medical Device Analytical Testing Outsourcing for Others
Medical Device Analytical Testing Outsourcing Market by Region:
- North America Medical Device Analytical Testing Outsourcing Market
- Europe Medical Device Analytical Testing Outsourcing Market
- Asia Pacific Medical Device Analytical Testing Outsourcing Market
- Latin America Medical Device Analytical Testing Outsourcing Market
- Middle East & Africa Medical Device Analytical Testing Outsourcing Market
- UEA Medical Device Analytical Testing Outsourcing Market
Frequently Asked Questions
What is the estimated market value of the global Medical Device Analytical Testing Outsourcing market?
The global Medical Device Analytical Testing Outsourcing market is estimated at US$ 10.96 Billion while expanding at a CAGR of 7.18% during the forecast period.
What is the estimated size of the global Medical Device Analytical Testing Outsourcing market in 2021?
The global Medical Device Analytical Testing Outsourcing market is estimated at US$ 5.11 Billion in 2021.
Which region is projected to garner maximum market share?
The U.S is projected to lead the market while procuring US$ 1.5 Billion while expanding at a CAGR of 7% during the forecast period.
What is the expected growth rate of China?
China is anticipated to grow at 5.5% CAGR
Which segment is anticipated to dominate the market?
The hospitals segment is predicted to lead the market with a CAGR of 6.15% during the assessment period.
Who are the key participants of the global Medical Device Analytical Testing Outsourcing market?
SGS, Toxikon, Inc, and Eurofins Scientific, Pace Analytical Services LLC, Intertek Group plc, Wuxi AppTec, North American Science Associates, Inc., Envigo, Charles River Laboratories International, Inc. and Medical Device Testing Services are some of the key participants of the market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Investment Feasibility Matrix 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Service 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032 5.3.1. Extractable and Leachable 5.3.2. Material Characterization 5.3.3. Physical Testing 5.3.4. Bioburden Testing 5.3.5. Sterility Testing 5.3.6. Other Tests 5.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021 5.5. Absolute $ Opportunity Analysis By Service, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032 6.3.1. Reprocessed Devices 6.3.2. Others 6.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2022-2032 7.3.1. Hospital 7.3.2. Others 7.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021 7.5. Absolute $ Opportunity Analysis By End-use, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Areas 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Areas, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Areas, 2022-2032 8.3.1. Cardiology 8.3.2. Diagnostic Imaging 8.3.3. Orthopedic 8.3.4. IVD 8.3.5. Ophthalmin 8.3.6. General & Plastic Surgery 8.3.7. Drug Delivery 8.3.8. Endoscopy 8.3.9. Dental 8.3.10. Diabetes Care 8.3.11. Others 8.4. Y-o-Y Growth Trend Analysis By Therapeutic Areas, 2017-2021 8.5. Absolute $ Opportunity Analysis By Therapeutic Areas, 2022-2032 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Service 10.2.3. By Device Type 10.2.4. By End-use 10.2.5. By Therapeutic Areas 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Service 10.3.3. By Device Type 10.3.4. By End-use 10.3.5. By Therapeutic Areas 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Service 11.2.3. By Device Type 11.2.4. By End-use 11.2.5. By Therapeutic Areas 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service 11.3.3. By Device Type 11.3.4. By End-use 11.3.5. By Therapeutic Areas 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. Italy 12.2.1.3. France 12.2.1.4. U.K. 12.2.1.5. Russia 12.2.1.6. BENELUX 12.2.1.7. Rest of Europe 12.2.2. By Service 12.2.3. By Device Type 12.2.4. By End-use 12.2.5. By Therapeutic Areas 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service 12.3.3. By Device Type 12.3.4. By End-use 12.3.5. By Therapeutic Areas 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. Rest of Asia Pacific 13.2.2. By Service 13.2.3. By Device Type 13.2.4. By End-use 13.2.5. By Therapeutic Areas 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service 13.3.3. By Device Type 13.3.4. By End-use 13.3.5. By Therapeutic Areas 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Turkey 14.2.1.4. Rest of Middle East and Africa 14.2.2. By Service 14.2.3. By Device Type 14.2.4. By End-use 14.2.5. By Therapeutic Areas 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Service 14.3.3. By Device Type 14.3.4. By End-use 14.3.5. By Therapeutic Areas 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Service 15.1.2.2. By Device Type 15.1.2.3. By End-use 15.1.2.4. By Therapeutic Areas 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Service 15.2.2.2. By Device Type 15.2.2.3. By End-use 15.2.2.4. By Therapeutic Areas 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Service 15.3.2.2. By Device Type 15.3.2.3. By End-use 15.3.2.4. By Therapeutic Areas 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Service 15.4.2.2. By Device Type 15.4.2.3. By End-use 15.4.2.4. By Therapeutic Areas 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Service 15.5.2.2. By Device Type 15.5.2.3. By End-use 15.5.2.4. By Therapeutic Areas 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Service 15.6.2.2. By Device Type 15.6.2.3. By End-use 15.6.2.4. By Therapeutic Areas 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Service 15.7.2.2. By Device Type 15.7.2.3. By End-use 15.7.2.4. By Therapeutic Areas 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Service 15.8.2.2. By Device Type 15.8.2.3. By End-use 15.8.2.4. By Therapeutic Areas 15.9. Russia 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Service 15.9.2.2. By Device Type 15.9.2.3. By End-use 15.9.2.4. By Therapeutic Areas 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Service 15.10.2.2. By Device Type 15.10.2.3. By End-use 15.10.2.4. By Therapeutic Areas 15.11. China 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Service 15.11.2.2. By Device Type 15.11.2.3. By End-use 15.11.2.4. By Therapeutic Areas 15.12. Japan 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Service 15.12.2.2. By Device Type 15.12.2.3. By End-use 15.12.2.4. By Therapeutic Areas 15.13. South Korea 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Service 15.13.2.2. By Device Type 15.13.2.3. By End-use 15.13.2.4. By Therapeutic Areas 15.14. GCC Countries 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Service 15.14.2.2. By Device Type 15.14.2.3. By End-use 15.14.2.4. By Therapeutic Areas 15.15. South Africa 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Service 15.15.2.2. By Device Type 15.15.2.3. By End-use 15.15.2.4. By Therapeutic Areas 15.16. Turkey 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Service 15.16.2.2. By Device Type 15.16.2.3. By End-use 15.16.2.4. By Therapeutic Areas 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Service 16.3.3. By Device Type 16.3.4. By End-use 16.3.5. By Therapeutic Areas 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. LabCorp 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Sgs Sa 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Eurofins Scientific 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Pace Analytical Services Llc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Intertek Group Plc 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Wuxi Apptec 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. North American Science Associates, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Envigo 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Charles River Laboratories International, Inc 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodolog
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 3: Global Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 4: Global Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 5: Global Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032 Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 7: North America Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 8: North America Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 9: North America Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 10: North America Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032 Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 12: Latin America Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 13: Latin America Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 14: Latin America Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 15: Latin America Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032 Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 17: Europe Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 18: Europe Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 19: Europe Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 20: Europe Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032 Table 21: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: Asia Pacific Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 23: Asia Pacific Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 24: Asia Pacific Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 25: Asia Pacific Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032 Table 26: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 27: Middle East and Africa Market Value (US$ Mn) Forecast by Service, 2017-2032 Table 28: Middle East and Africa Market Value (US$ Mn) Forecast by Device Type, 2017-2032 Table 29: Middle East and Africa Market Value (US$ Mn) Forecast by End-use, 2017-2032 Table 30: Middle East and Africa Market Value (US$ Mn) Forecast by Therapeutic Areas, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Service, 2022-2032 Figure 2: Global Market Value (US$ Mn) by Device Type, 2022-2032 Figure 3: Global Market Value (US$ Mn) by End-use, 2022-2032 Figure 4: Global Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 9: Global Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 10: Global Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 11: Global Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 12: Global Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 13: Global Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 14: Global Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 15: Global Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 16: Global Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 17: Global Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 18: Global Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 19: Global Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 20: Global Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 21: Global Market Attractiveness by Service, 2022-2032 Figure 22: Global Market Attractiveness by Device Type, 2022-2032 Figure 23: Global Market Attractiveness by End-use, 2022-2032 Figure 24: Global Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 25: Global Market Attractiveness by Region, 2022-2032 Figure 26: North America Market Value (US$ Mn) by Service, 2022-2032 Figure 27: North America Market Value (US$ Mn) by Device Type, 2022-2032 Figure 28: North America Market Value (US$ Mn) by End-use, 2022-2032 Figure 29: North America Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 34: North America Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 35: North America Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 37: North America Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 38: North America Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 39: North America Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 40: North America Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 41: North America Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 42: North America Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 43: North America Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 44: North America Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 45: North America Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 46: North America Market Attractiveness by Service, 2022-2032 Figure 47: North America Market Attractiveness by Device Type, 2022-2032 Figure 48: North America Market Attractiveness by End-use, 2022-2032 Figure 49: North America Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 50: North America Market Attractiveness by Country, 2022-2032 Figure 51: Latin America Market Value (US$ Mn) by Service, 2022-2032 Figure 52: Latin America Market Value (US$ Mn) by Device Type, 2022-2032 Figure 53: Latin America Market Value (US$ Mn) by End-use, 2022-2032 Figure 54: Latin America Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 59: Latin America Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 62: Latin America Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 65: Latin America Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 66: Latin America Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 68: Latin America Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 69: Latin America Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 71: Latin America Market Attractiveness by Service, 2022-2032 Figure 72: Latin America Market Attractiveness by Device Type, 2022-2032 Figure 73: Latin America Market Attractiveness by End-use, 2022-2032 Figure 74: Latin America Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 75: Latin America Market Attractiveness by Country, 2022-2032 Figure 76: Europe Market Value (US$ Mn) by Service, 2022-2032 Figure 77: Europe Market Value (US$ Mn) by Device Type, 2022-2032 Figure 78: Europe Market Value (US$ Mn) by End-use, 2022-2032 Figure 79: Europe Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 84: Europe Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 85: Europe Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 87: Europe Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 88: Europe Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 90: Europe Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 91: Europe Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 92: Europe Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 93: Europe Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 94: Europe Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 95: Europe Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 96: Europe Market Attractiveness by Service, 2022-2032 Figure 97: Europe Market Attractiveness by Device Type, 2022-2032 Figure 98: Europe Market Attractiveness by End-use, 2022-2032 Figure 99: Europe Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 100: Europe Market Attractiveness by Country, 2022-2032 Figure 101: Asia Pacific Market Value (US$ Mn) by Service, 2022-2032 Figure 102: Asia Pacific Market Value (US$ Mn) by Device Type, 2022-2032 Figure 103: Asia Pacific Market Value (US$ Mn) by End-use, 2022-2032 Figure 104: Asia Pacific Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 105: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 106: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 109: Asia Pacific Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 112: Asia Pacific Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 115: Asia Pacific Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 118: Asia Pacific Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 121: Asia Pacific Market Attractiveness by Service, 2022-2032 Figure 122: Asia Pacific Market Attractiveness by Device Type, 2022-2032 Figure 123: Asia Pacific Market Attractiveness by End-use, 2022-2032 Figure 124: Asia Pacific Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 125: Asia Pacific Market Attractiveness by Country, 2022-2032 Figure 126: Middle East and Africa Market Value (US$ Mn) by Service, 2022-2032 Figure 127: Middle East and Africa Market Value (US$ Mn) by Device Type, 2022-2032 Figure 128: Middle East and Africa Market Value (US$ Mn) by End-use, 2022-2032 Figure 129: Middle East and Africa Market Value (US$ Mn) by Therapeutic Areas, 2022-2032 Figure 130: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032 Figure 131: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 134: Middle East and Africa Market Value (US$ Mn) Analysis by Service, 2017-2032 Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Service, 2022-2032 Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Service, 2022-2032 Figure 137: Middle East and Africa Market Value (US$ Mn) Analysis by Device Type, 2017-2032 Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 140: Middle East and Africa Market Value (US$ Mn) Analysis by End-use, 2017-2032 Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by End-use, 2022-2032 Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-use, 2022-2032 Figure 143: Middle East and Africa Market Value (US$ Mn) Analysis by Therapeutic Areas, 2017-2032 Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by Therapeutic Areas, 2022-2032 Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by Therapeutic Areas, 2022-2032 Figure 146: Middle East and Africa Market Attractiveness by Service, 2022-2032 Figure 147: Middle East and Africa Market Attractiveness by Device Type, 2022-2032 Figure 148: Middle East and Africa Market Attractiveness by End-use, 2022-2032 Figure 149: Middle East and Africa Market Attractiveness by Therapeutic Areas, 2022-2032 Figure 150: Middle East and Africa Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
